Efficacy of topical timolol in acne scars are treating with TCACROSS.
Phase 2
- Conditions
- Atrophic acne scar.Scar conditions and fibrosis of skinL90.5
- Registration Number
- IRCT20191208045657N1
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Bilateral facial atrophic acne scars
Minimum age 18 years
Exclusion Criteria
Active acne lesions
Prone to make colloids
Immunocompromised
Active herpes infection
Pregnancy or lactation
Systemic treatment of isotretinoin or immunosuppressant drugs for the past 6 months.
History of sensitivity to any of the materials used in the study
major depression
Patients with low blood pressure and bradycardia or any history of them
History of CHF
History of MI
History of cardiac arrhythmia
Patients with asthma or bronchospasm or or history of them
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of facial atrophic scars. Timepoint: The severity of acne scars is assessed at the beginning of the study, 2 weeks later, and at week 12. Method of measurement: Qualitative Global Scarring Grading System (Goodman and Baron).
- Secondary Outcome Measures
Name Time Method